Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

EGFL7 anticorps (AA 30-80)

EGFL7 Reactivité: Humain, Souris, Rat ELISA, IHC (p) Hôte: Lapin Polyclonal unconjugated
N° du produit ABIN733988
  • Antigène Voir toutes EGFL7 Anticorps
    EGFL7 (EGF-Like-Domain, Multiple 7 (EGFL7))
    Épitope
    • 4
    • 4
    • 3
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 30-80
    Reactivité
    Humain, Souris, Rat
    Hôte
    • 21
    • 8
    • 1
    • 1
    • 1
    Lapin
    Clonalité
    • 25
    • 7
    Polyclonal
    Conjugué
    • 21
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Cet anticorp EGFL7 est non-conjugé
    Application
    • 19
    • 15
    • 4
    • 4
    • 3
    • 3
    • 2
    • 2
    ELISA, Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))
    Homologie
    Human,Mouse,Rat
    Purification
    Purified by Protein A.
    Immunogène
    KLH conjugated synthetic peptide derived from mouse EGFL7
    Isotype
    IgG
    Top Product
    Discover our top product EGFL7 Anticorps primaire
  • Indications d'application
    WB 1:100-1000
    IHC-P 1:100-500
    IF(IHC-P) 1:50-200
    IF(ICC) 1:50-200
    Restrictions
    For Research Use only
  • Format
    Liquid
    Concentration
    1 μg/μL
    Buffer
    0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.
    Agent conservateur
    Sodium azide
    Précaution d'utilisation
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
    Stock
    4 °C,-20 °C
    Stockage commentaire
    Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.
    Date de péremption
    12 months
  • Huang, Yuan, Wan, Liu, Chen, Zhan, Li: "VE-statin/Egfl7 expression in malignant glioma and its relevant molecular network." dans: International journal of clinical and experimental pathology, Vol. 7, Issue 3, pp. 1022-31, (2014) (PubMed).

  • Antigène
    EGFL7 (EGF-Like-Domain, Multiple 7 (EGFL7))
    Autre désignation
    Egfl7 (EGFL7 Produits)
    Synonymes
    anticorps egfl7, anticorps MGC53105, anticorps EGFL7, anticorps zgc:136669, anticorps zgc:152804, anticorps zneu1, anticorps xegfl7, anticorps MGC147423, anticorps VE-statin, anticorps Zneu1, anticorps NEU1, anticorps RP11-251M1.2, anticorps VE-STATIN, anticorps ZNEU1, anticorps EGF like domain multiple 7 S homeolog, anticorps EGF like domain multiple 7, anticorps EGF-like-domain, multiple 7, anticorps EGF-like domain 7, anticorps egfl7.S, anticorps EGFL7, anticorps egfl7, anticorps Egfl7
    Sujet

    Synonyms: Zneu1, VE-statin, Epidermal growth factor-like protein 7, EGF-like protein 7, Multiple epidermal growth factor-like domains protein 7, Multiple EGF-like domains protein 7, NOTCH4-like protein, Vascular endothelial statin, Egfl7, Megf7

    Background: Regulates vascular tubulogenesis in vivo. Inhibits platelet-derived growth factor (PDGF)-BB-induced smooth muscle cell migration and promotes endothelial cell adhesion to the extracellular matrix and angiogenesis.

    ID gène
    353156
    UniProt
    Q9QXT5
Vous êtes ici:
Support technique